Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma

Journal of Surgical Oncology

Volumn 51, Issue 2, 1992, Pages 122-125

  Fowler, Wyatt C ^a   Eisenberg, Burton L ^a   Hoffman, John P ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

chemotherapy; downstaging; liver

Indexed keywords

FLUOROURACIL; FOLINIC ACID; SPARFOSIC ACID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANTINEOPLASTIC AGENTS; ASPARTIC ACID; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMAN; LEUCOVORIN; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PHOSPHONOACETIC ACID; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0026761374     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.2930510212     Document Type: Article

References (23)

1. Cancer Statistics 1986
2. Clinical perspective of human coloreclal cancer metastasis
3. Phase II study of biochemical modulation of fluorouracil by low‐dose PALA in patients with colorectal cancer
4. Treatment of advanced‐stage colorectal adenocarcinoma with fluorouracil and high‐dose leucovorin calcium: A pilot study
5. Fluorouracil and recombinant alfa‐2a‐interferon: An active regimen against advanced colorectal carcinoma
6. Chemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
7. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma
8. A prospective randomized trial of 5‐fluorouracil versus 5‐fluorouracil and high‐dose leucovorin and methotrexate in previously untreated patients with advanced colorectal carcinoma
9. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history
10. Resection of the liver for colorectal carcinoma metastases: A multiinstitutional study of patterns of recurrence
11. Resection of the liver for colorectal carcinoma metastases: A multiinstitutional study of indications for resection
12. Morbidity and mortality of hepatic resection for metastatic colorectal carcinoma
13. Resection of the liver for colorectal carcinoma metastases. A multi‐institutional study of long‐term survivors
14. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. 1. Treatement by hepatic resection
15. Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy
16. Recurrence of colorectal cancer after hepatic resection
17. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach
18. Resection of liver metastases—When is it worthwhile?
19. Hepatic resection for isolated metastasis from colorectal carcinoma
20. Hepatic resection for primary and metastatic tumors
21. Personal experience with 411 hepatic resections
22. Experience with colorectal carcinoma metastatic to the liver
23. Hepatic resection for metastases of the colon and rectum